Controlled release of Rituximab from gold nanoparticles for phototherapy of malignant cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Controlled release of Rituximab from gold nanoparticles for phototherapy of malignant cells

Published:2012-09 Issue:2 Volume:162 Page:303-309
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Bisker Gili,Yeheskely-Hayon Daniella,Minai Limor,Yelin Dvir

Funder

European Research Council starting grant

Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference84 articles.

1. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

2. Nanoparticle therapeutics: an emerging treatment modality for cancer;Davis;Nat. Rev. Drug Discov.,2008

3. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers;Wolinsky;J. Control. Release,2012

4. Nano is better than micro for targeted vaccine delivery;Park;J. Control. Release,2010

5. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology;Moein Moghimi;Anticancer Agents Med. Chem.,2006

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials;Microchimica Acta;2024-08-16

2. In Vitro Evaluation of Colistin Conjugated with Chitosan-Capped Gold Nanoparticles as a Possible Formulation Applied in a Metered-Dose Inhaler;Antibiotics;2024-07-06

3. Structural Insights into Antibacterial Payload Release from Gold Nanoparticles Bound to E. coli Peptide Deformylase;ChemMedChem;2023-12-06

4. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments;Journal of Nanobiotechnology;2023-03-25

5. A novel gold-polymer-antibody conjugate for targeted (radio-photothermal) treatment of HepG2 cells;Journal of Biomaterials Science, Polymer Edition;2022-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3